Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

AR T878A

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

AR T878A	Prostate Cancer	AR T878A	Prostate Cancer	PCM-075 Sensitive: C3 – Early Trials PCM-075 Sensitive : C3	PCM-075 Sensitive: C3 – Early Trials PCM-075 Sensitive : C3
AR T878A	Prostate Cancer	AR T878A	Prostate Cancer	apalutamide Resistant: C3 – Early Trials apalutamide Resistant : C3	apalutamide Resistant: C3 – Early Trials apalutamide Resistant : C3
AR T878A	Prostate Cancer	AR T878A	Prostate Cancer	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3
AR T878A	Prostate Cancer	AR T878A	Prostate Cancer	ARV-110 Sensitive: C3 – Early Trials ARV-110 Sensitive : C3	ARV-110 Sensitive: C3 – Early Trials ARV-110 Sensitive : C3
AR T878A	Prostate Cancer	AR T878A	Prostate Cancer	darolutamide Resistant: C3 – Early Trials darolutamide Resistant : C3	darolutamide Resistant: C3 – Early Trials darolutamide Resistant : C3